|
gptkbp:instance_of
|
gptkb:Company
|
|
gptkbp:acquisition
|
Acquired XYZ Corp in 2015
|
|
gptkbp:awards
|
Best Biotech Company 2021
|
|
gptkbp:benefits
|
gptkb:Health_Insurance
|
|
gptkbp:brand
|
Strong Customer Loyalty
|
|
gptkbp:brand_recognition
|
Strong in Biotech Sector
|
|
gptkbp:business_model
|
B2 B and B2 C
|
|
gptkbp:capacity
|
1 million shares
|
|
gptkbp:categories
|
Therapeutics
|
|
gptkbp:ceo
|
gptkb:John_Doe
|
|
gptkbp:clinical_trial
|
Ongoing for New Drug
|
|
gptkbp:collaborations
|
With Leading Universities
|
|
gptkbp:community_engagement
|
Health Awareness Campaigns
|
|
gptkbp:community_impact
|
Positive Health Outcomes
|
|
gptkbp:competitors
|
gptkb:ABC_Biotech
|
|
gptkbp:conducts_research_on
|
gptkb:Dr._Emily_White
|
|
gptkbp:conflict
|
Regulatory Hurdles
|
|
gptkbp:customer_base
|
Hospitals and Clinics
|
|
gptkbp:customer_feedback
|
Positive Reviews
|
|
gptkbp:customer_satisfaction
|
High Satisfaction Scores
|
|
gptkbp:customer_support
|
24/7 Service
|
|
gptkbp:distribution
|
Worldwide
|
|
gptkbp:economic_impact
|
Entering Asian Markets
|
|
gptkbp:financial_performance
|
Consistent Growth
|
|
gptkbp:financial_reports
|
Quarterly Earnings Reports
|
|
gptkbp:financial_stability
|
Strong Balance Sheet
|
|
gptkbp:focus_area
|
Blood Products
|
|
gptkbp:founder
|
gptkb:Jane_Smith
|
|
gptkbp:future_plans
|
Expand into Europe
|
|
gptkbp:global_presence
|
Operations in 10 Countries
|
|
gptkbp:governance
|
gptkb:Board_of_Directors
|
|
gptkbp:grants
|
Received from NIH
|
|
gptkbp:has_diversity_initiatives
|
Inclusive Hiring Practices
|
|
gptkbp:has_partnerships_with
|
Collaborations with Pharma Companies
|
|
gptkbp:headquarters
|
gptkb:United_States
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
BLDP
|
|
gptkbp:industry
|
gptkb:biotechnology
|
|
gptkbp:innovation
|
New Formulations
Encourages Creativity
|
|
gptkbp:invention
|
20 active patents
|
|
gptkbp:investment
|
Venture Capital Firms
Blockchain for Supply Chain
R& D in Gene Therapy
|
|
gptkbp:investment_strategy
|
Up 15% in 2023
|
|
gptkbp:market
|
Annual Industry Reports
|
|
gptkbp:market_cap
|
500 million USD
|
|
gptkbp:market_launch
|
New Plasma Treatment in 2022
|
|
gptkbp:market_position
|
Top 10 Biotech Companies
|
|
gptkbp:marketing_strategy
|
Focus on Innovation
|
|
gptkbp:mentor
|
Top Investment Firms
|
|
gptkbp:number_of_employees
|
gptkb:200
|
|
gptkbp:partnerships
|
Joint Ventures
Various Healthcare Organizations
|
|
gptkbp:product
|
Agile Methodologies
|
|
gptkbp:products
|
Blood Plasma
|
|
gptkbp:regulatory_compliance
|
FDA Approved
|
|
gptkbp:research_focus
|
Transfusion Medicine
|
|
gptkbp:revenue
|
100 million USD
|
|
gptkbp:risk_management
|
Comprehensive Strategies
|
|
gptkbp:social_responsibility
|
Community Health Initiatives
Philanthropic Activities
|
|
gptkbp:stock_exchange
|
gptkb:True
gptkb:NASDAQ
|
|
gptkbp:stock_symbol
|
gptkb:BLDP
|
|
gptkbp:strategic_goals
|
Market Leadership
|
|
gptkbp:student_enrollment
|
High Retention Rate
|
|
gptkbp:subsidiaries
|
gptkb:BLDP_Therapeutics
|
|
gptkbp:supply_chain
|
Efficient Logistics
Global Suppliers
|
|
gptkbp:sustainability_practices
|
Eco-friendly Manufacturing
|
|
gptkbp:training
|
Continuous Learning Programs
|
|
gptkbp:user_engagement
|
High Engagement Levels
|
|
gptkbp:uses_technology
|
AI in Research
|
|
gptkbp:website
|
www.bldp.com
|
|
gptkbp:year_established
|
gptkb:2000
|
|
gptkbp:bfsParent
|
gptkb:Ballard_Power_Systems
|
|
gptkbp:bfsLayer
|
6
|